BMI as a barrier to orthopedic surgery doesn't make sense for patient health.
Want to stay on top of the science and politics driving biotech today? Sign up t...
Drug Farm’s ALPK1 inhibitor DF-003 is being investigated in a Phase I trial for ...
If new treatments are shown to maintain weight loss, they will become game chang...
MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures ...
The acquired programme consists of antibiotics against gram-negative bacteria, i...
PCM Trials, a Denver, USA based leader in providing mobile research nurses for d...
Arena Bioworks has already lured top scientists from academic labs, raising some...
What STAT readers think about JPM's locked lactation room, covering weight loss ...
The UK nod for Agamree, which comes after previous approvals in Europe and the U...
Dermavant will include these findings in an upcoming supplemental new drug appli...
Ji Xing Pharmaceuticals acquired Biogen’s BIIB131 for advancing worldwide clinic...
Contract research organisation ClinChoice has acquired CSI Medical Research, mar...
Cereno Scientific has announced a partnership with CordenPharma to scale up manu...
SyntheticGestalt and Enamine have announced a collaboration to develop a suite o...
Pauline Frank reflects on her talk at the 2023 CTO Europe conference and highlig...
